Related Experiment Video
Updated: Aug 15, 2026

Detection of Signaling Effector-Complexes Downstream of BMP4 Using in situ PLA, a Proximity Ligation Assay
Published on: March 3, 2011
Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor
1Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract:
Although ErbB receptors have been implicated in the progression of prostate cancer, little is known about proteins that may mediate their interactions with the androgen receptor (AR). Ebp1, a protein cloned via its association with the ErbB3 receptor, binds the AR and inhibits androgen-regulated transactivation of wild-type AR in COS cells. As the complement of coregulators in different cells are important for AR activity, we determined the effect of Ebp1 on AR function in prostate cancer cell lines. In addition, we examined the regulation of Ebp1 function by the ErbB3/4 ligand heregulin (HRG). In this study, we demonstrate, using several natural AR-regulated promoters, that Ebp1 repressed transcriptional activation of wild-type AR in prostate cancer cell lines. Downregulation of Ebp1 expression in LNCaP cells using siRNA resulted in activation of AR in the absence of androgen. Ebp1 associated with ErbB3 in LNCaP cells in the absence of HRG, but HRG induced the dissociation of Ebp1 from ErbB3. In contrast, HRG treatment enhanced both the association of Ebp1 with AR and also the ability of Ebp1 to repress AR transactivation. These studies suggest that Ebp1 is an AR corepressor whose biological activity can be regulated by the ErbB3 ligand, HRG.
Insights
Ebp1 acts as a corepressor for the androgen receptor (AR) in prostate cancer cells. Its interaction with AR and repressive activity are modulated by heregulin (HRG), a ligand for ErbB3/4 receptors.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- ErbB receptors are involved in prostate cancer progression.
- The interaction between ErbB receptors and the androgen receptor (AR) is not well understood.
- Ebp1 protein, identified through its association with ErbB3, interacts with AR.
Purpose of the Study:
- To investigate the effect of Ebp1 on AR function in prostate cancer cell lines.
- To examine the regulation of Ebp1 by heregulin (HRG), an ErbB3/4 ligand.
- To elucidate the role of Ebp1 as a potential AR coregulator.
Main Methods:
- Utilized natural AR-regulated promoters to assess transcriptional activation.
- Employed siRNA to downregulate Ebp1 expression in LNCaP cells.
- Investigated protein-protein interactions using co-immunoprecipitation assays.
- Analyzed the impact of HRG treatment on Ebp1-ErbB3 and Ebp1-AR associations.
Main Results:
- Ebp1 repressed the transcriptional activation of wild-type AR in prostate cancer cell lines.
- Downregulation of Ebp1 led to AR activation in the absence of androgen.
- Ebp1 associated with ErbB3 in LNCaP cells, and HRG induced their dissociation.
- HRG treatment enhanced Ebp1's association with AR and its repressive activity.
Conclusions:
- Ebp1 functions as an AR corepressor in prostate cancer.
- Ebp1's corepressor activity is regulated by the ErbB3/4 ligand, HRG.
- These findings highlight a novel regulatory mechanism involving Ebp1, AR, and ErbB signaling in prostate cancer.
More Related Videos
09:07Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Negative Regulator Molecules
Cell Specific Gene Expression
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal